PRECEDE BIO
Dead / Abandoned — Abandoned — express abandonment (as of 06 Feb 2024)
What this means for you
This application is over — abandoned 29 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97292956
- Mark type
- Stylized text
- Filed
- 03 Mar 2022
- Abandoned
- 29 Jan 2024
- Attorney of record
- Caitlin R. Byczko
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals' research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product
- Class 044 — Medical, beauty and agricultural services: medical testing and diagnostic services; clinical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states
Owner
- PRECEDE BIOSCIENCES, INC., BOSTON, MA, US
- Nuscan Diagnostics, Inc., Boston, MA, US
Prosecution history
- 06 Feb 2024 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 06 Feb 2024 — ABANDONMENT - EXPRESS MAILED
- 29 Jan 2024 — TEAS EXPRESS ABANDONMENT RECEIVED
- 27 Oct 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 Oct 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 28 Jul 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 28 Jul 2023 — FINAL REFUSAL E-MAILED
- 28 Jul 2023 — FINAL REFUSAL WRITTEN
- 26 Jul 2023 — DIVISIONAL PROCESSING COMPLETE
- 30 May 2023 — DIVISIONAL REQUEST RECEIVED
- 25 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 May 2023 — TEAS REQUEST TO DIVIDE RECEIVED